Nasal Packing Duration and Development of Pharyngitis After Septorhinoplasty Surgery

NCT06291402 · tracked via the Priya Life Science Egypt tracker

Sponsor

Al-Azhar University

Phase

Observational

Started

2024-03-10

Last updated

2026-01-06

Condition(s) studied

Rhinitis

Study summary

Septoplasty or septal reconstruction is a corrective surgical procedure performed to straighten the nasal septum. It may be associated with numerous complications. To minimize these complications, both nasal cavities are frequently packed with different types of nasal packing. In our study we will try to find relationship between duration of nasal packing and postrhinoplasty sore throat and pharyngitis.

Eligibility

Sex

ALL

Min age

20 Years

Max age

40 Years

Healthy volunteers

Inclusion Criteria: * ASA I and II patients * aged from 20 to 40 years old * undergo septorhinoplasty Exclusion Criteria: * Bleeding disorders * Uncontrolled hypertension * Cardiovascular diseases * Uncontrolled diabetes mellitus * Collagen disorders * Pregnancy

Primary outcome measure(s)

Sore throat — 48 hours postoperatively
The incidence of Sore throat will be graded as 0 = Nil, 1 = Mild, 2 = Moderate and 3 = Severe as possible.

Trial sites (1)

Facility	City	Region	Status
Neveen Kohaf	Tanta	Egypt	Recruiting

More Al-Azhar University trials in Egypt

Management of Early Onset Scoliosis by Active Apex Correction Technique Recruiting

A Crossover Clinical Study to Evaluate the Effect of Chitosan Mouthwash on Recurrence of Black Stains in Pediatric Patients Recruiting

"Augmented Reality-Assisted Miniscrew Placement in Orthodontics: A Clinical Trial" Starting soon

Low-Intensity Shock Wave Therapy for Refractory Overactive Bladder in Women Starting soon

Evaluation of the Efficacy of Topical Application of Liquid Nitrogen and Ascorbic Acid in Treatment of Gingival Pigmentation Enrolling by invitation

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06291402 on ClinicalTrials.gov ↗ ← All trials in Egypt